Actually, a combination of PCA3 and TMPRSS2:ERG test has been shown to reduce the number of unnecessary prostate biopsy and improve the accuracy of PCa diagnosis (Table 3). This evidence concerns the gene TMPRSS2 and posterior cortical atrophy.